APVO
Price
$9.05
Change
+$0.04 (+0.44%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
8.99M
Intraday BUY SELL Signals
BDRX
Price
$2.14
Change
+$0.05 (+2.39%)
Updated
Jan 15, 04:58 PM (EDT)
Capitalization
1.74M
Intraday BUY SELL Signals
Interact to see
Advertisement

APVO vs BDRX

Header iconAPVO vs BDRX Comparison
Open Charts APVO vs BDRXBanner chart's image
Aptevo Therapeutics
Price$9.05
Change+$0.04 (+0.44%)
Volume$1.47K
Capitalization8.99M
Biodexa Pharmaceuticals
Price$2.14
Change+$0.05 (+2.39%)
Volume$291
Capitalization1.74M
APVO vs BDRX Comparison Chart in %
APVO
Daily Signal:
Gain/Loss:
BDRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APVO vs. BDRX commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and BDRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (APVO: $9.01 vs. BDRX: $2.09)
Brand notoriety: APVO and BDRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 32% vs. BDRX: 10%
Market capitalization -- APVO: $8.99M vs. BDRX: $1.74M
APVO [@Biotechnology] is valued at $8.99M. BDRX’s [@Biotechnology] market capitalization is $1.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 1 FA rating(s) are green whileBDRX’s FA Score has 1 green FA rating(s).

  • APVO’s FA Score: 1 green, 4 red.
  • BDRX’s FA Score: 1 green, 4 red.
According to our system of comparison, APVO is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 5 TA indicator(s) are bullish while BDRX’s TA Score has 3 bullish TA indicator(s).

  • APVO’s TA Score: 5 bullish, 3 bearish.
  • BDRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APVO is a better buy in the short-term than BDRX.

Price Growth

APVO (@Biotechnology) experienced а +1.12% price change this week, while BDRX (@Biotechnology) price change was -13.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APVO($8.99M) has a higher market cap than BDRX($1.74M). APVO YTD gains are higher at: -4.507 vs. BDRX (-7.930). BDRX has higher annual earnings (EBITDA): -5.56M vs. APVO (-26.47M). APVO (0) and BDRX (0) have equivalent revenues.
APVOBDRXAPVO / BDRX
Capitalization8.99M1.74M518%
EBITDA-26.47M-5.56M476%
Gain YTD-4.507-7.93057%
P/E Ratio0.00N/A-
Revenue00-
Total Cash3.23MN/A-
Total Debt3.99MN/A-
FUNDAMENTALS RATINGS
APVO vs BDRX: Fundamental Ratings
APVO
BDRX
OUTLOOK RATING
1..100
2785
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9898
P/E GROWTH RATING
1..100
4895
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APVO's Valuation (10) in the Biotechnology industry is in the same range as BDRX (24). This means that APVO’s stock grew similarly to BDRX’s over the last 12 months.

APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BDRX (100). This means that APVO’s stock grew similarly to BDRX’s over the last 12 months.

BDRX's SMR Rating (99) in the Biotechnology industry is in the same range as APVO (100). This means that BDRX’s stock grew similarly to APVO’s over the last 12 months.

BDRX's Price Growth Rating (98) in the Biotechnology industry is in the same range as APVO (98). This means that BDRX’s stock grew similarly to APVO’s over the last 12 months.

APVO's P/E Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for BDRX (95). This means that APVO’s stock grew somewhat faster than BDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APVOBDRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 7 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APVO
Daily Signal:
Gain/Loss:
BDRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTEN0.04N/A
+4.75%
Mingteng International Corp
NOG22.930.48
+2.14%
Northern Oil and Gas
QVCGA9.360.15
+1.63%
QVC Group Inc
IVZ28.25-0.05
-0.18%
Invesco Ltd
MITK10.25-0.21
-2.01%
Mitek Systems

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
+1.41%
GOSS - APVO
42%
Loosely correlated
-4.14%
ENLV - APVO
39%
Loosely correlated
+9.26%
KROS - APVO
37%
Loosely correlated
+0.15%
AXON - APVO
33%
Loosely correlated
-1.92%
BDRX - APVO
30%
Poorly correlated
-8.73%
More

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-8.73%
LVTX - BDRX
41%
Loosely correlated
N/A
SCNI - BDRX
32%
Poorly correlated
+15.59%
PRQR - BDRX
32%
Poorly correlated
N/A
AVTX - BDRX
32%
Poorly correlated
-5.87%
KRRO - BDRX
31%
Poorly correlated
+0.11%
More